GB0113232D0 - Chemical process - Google Patents

Chemical process

Info

Publication number
GB0113232D0
GB0113232D0 GBGB0113232.3A GB0113232A GB0113232D0 GB 0113232 D0 GB0113232 D0 GB 0113232D0 GB 0113232 A GB0113232 A GB 0113232A GB 0113232 D0 GB0113232 D0 GB 0113232D0
Authority
GB
United Kingdom
Prior art keywords
chemical process
compound
polymorphs
solvates
preparing
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB0113232.3A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Glaxo Group Ltd
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Priority to GBGB0113232.3A priority Critical patent/GB0113232D0/en
Publication of GB0113232D0 publication Critical patent/GB0113232D0/en
Priority to CZ20033256A priority patent/CZ20033256A3/cs
Priority to MXPA03010943A priority patent/MXPA03010943A/es
Priority to AU2002317764A priority patent/AU2002317764B2/en
Priority to NZ529486A priority patent/NZ529486A/en
Priority to CNA02810885XA priority patent/CN1551871A/zh
Priority to CA002448101A priority patent/CA2448101A1/en
Priority to IL15864102A priority patent/IL158641A0/xx
Priority to PL02367114A priority patent/PL367114A1/xx
Priority to EP02747330A priority patent/EP1395572B1/en
Priority to JP2003500072A priority patent/JP2004532265A/ja
Priority to HU0400117A priority patent/HUP0400117A3/hu
Priority to AT02747330T priority patent/ATE315556T1/de
Priority to KR10-2003-7015677A priority patent/KR20040007631A/ko
Priority to DE60208682T priority patent/DE60208682T2/de
Priority to BR0209892-0A priority patent/BR0209892A/pt
Priority to ES02747330T priority patent/ES2256493T3/es
Priority to PCT/EP2002/005884 priority patent/WO2002096893A1/en
Priority to US10/478,260 priority patent/US7244849B2/en
Priority to ZA200308570A priority patent/ZA200308570B/en
Priority to CO03104438A priority patent/CO5540298A2/es
Priority to NO20035313A priority patent/NO20035313L/no
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/32—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D277/56—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Diabetes (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Hospice & Palliative Care (AREA)
  • Child & Adolescent Psychology (AREA)
  • Nutrition Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Steroid Compounds (AREA)
  • Physical Or Chemical Processes And Apparatus (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
GBGB0113232.3A 2001-05-31 2001-05-31 Chemical process Ceased GB0113232D0 (en)

Priority Applications (22)

Application Number Priority Date Filing Date Title
GBGB0113232.3A GB0113232D0 (en) 2001-05-31 2001-05-31 Chemical process
US10/478,260 US7244849B2 (en) 2001-05-31 2002-05-29 Process for preparing a thiazole PPAR-ligand and polymorphs thereof
JP2003500072A JP2004532265A (ja) 2001-05-31 2002-05-29 チアゾールｐｐａｒリガンドおよびその多形体の調製方法
AT02747330T ATE315556T1 (de) 2001-05-31 2002-05-29 Verfahren zur herstellung eines thiazol-ppar- liganden sowie dessen polymorphe
AU2002317764A AU2002317764B2 (en) 2001-05-31 2002-05-29 Process for preparing a thialzole PPAR-ligand and polymorphs thereof
NZ529486A NZ529486A (en) 2001-05-31 2002-05-29 Process for preparing a thiazole PPAR-ligand and polymorphs thereof
CNA02810885XA CN1551871A (zh) 2001-05-31 2002-05-29 制备噻唑ppar-配体及其多晶型物的方法
CA002448101A CA2448101A1 (en) 2001-05-31 2002-05-29 Process for preparing a thialzole ppar-ligand and polymorphs thereof
IL15864102A IL158641A0 (en) 2001-05-31 2002-05-29 Process for preparing a thiazole ppar-ligand and polymorphs thereof
PL02367114A PL367114A1 (en) 2001-05-31 2002-05-29 Process for preparing a thialzole ppar-ligand and polymorphs thereof
EP02747330A EP1395572B1 (en) 2001-05-31 2002-05-29 Process for preparing a thiazole ppar-ligand and polymorphs thereof
CZ20033256A CZ20033256A3 (en) 2001-05-31 2002-05-29 Process for preparing a thiazole ppar-ligand and polymorphs thereof
HU0400117A HUP0400117A3 (en) 2001-05-31 2002-05-29 Polymorphs of 2-methyl-2-[4-({[-4methyl-2-(4-trifluoromethyl-phenyl)-thiazol-5-carbonyl]-amino}-methyl)-phenoxy]-propionic acid, process for their preparation, their use and pharmaceurical compositions containing them
MXPA03010943A MXPA03010943A (es) 2001-05-31 2002-05-29 Proceso para preparar un ligando de ppar de tiazol y polimorfos del mismo.
KR10-2003-7015677A KR20040007631A (ko) 2001-05-31 2002-05-29 티아졸 ｐｐａｒ-리간드 및 이의 다형체의 제조 방법
DE60208682T DE60208682T2 (de) 2001-05-31 2002-05-29 Verfahren zur herstellung eines thiazol-ppar-liganden sowie dessen polymorphe
BR0209892-0A BR0209892A (pt) 2001-05-31 2002-05-29 Método de preparação de um composto, composto, composição farmacêutica, uso de um composto, e, método de tratamento de um paciente sofrendo de uma doença ou condição mediada por hppar alfa
ES02747330T ES2256493T3 (es) 2001-05-31 2002-05-29 Procedimiento para la preparacion de un ligando tiazol ppar y polimorfos del mismo.
PCT/EP2002/005884 WO2002096893A1 (en) 2001-05-31 2002-05-29 Process for preparing a thialzole ppar-ligand and polymorphs thereof
ZA200308570A ZA200308570B (en) 2001-05-31 2003-11-03 Process for preparing a thiazole PPAR-ligand and polymorphs thereof.
CO03104438A CO5540298A2 (es) 2001-05-31 2003-11-26 Proceso para preparar un ligando de ppar de tiazol y polimorfos del mismo
NO20035313A NO20035313L (no) 2001-05-31 2003-11-28 Fremgangsmåte for fremstilling av tialzol PPAR-ligand og polymorfer derav

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0113232.3A GB0113232D0 (en) 2001-05-31 2001-05-31 Chemical process

Publications (1)

Publication Number Publication Date
GB0113232D0 true GB0113232D0 (en) 2001-07-25

Family

ID=9915637

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB0113232.3A Ceased GB0113232D0 (en) 2001-05-31 2001-05-31 Chemical process

Country Status (22)

Country Link
US (1) US7244849B2 (enExample)
EP (1) EP1395572B1 (enExample)
JP (1) JP2004532265A (enExample)
KR (1) KR20040007631A (enExample)
CN (1) CN1551871A (enExample)
AT (1) ATE315556T1 (enExample)
AU (1) AU2002317764B2 (enExample)
BR (1) BR0209892A (enExample)
CA (1) CA2448101A1 (enExample)
CO (1) CO5540298A2 (enExample)
CZ (1) CZ20033256A3 (enExample)
DE (1) DE60208682T2 (enExample)
ES (1) ES2256493T3 (enExample)
GB (1) GB0113232D0 (enExample)
HU (1) HUP0400117A3 (enExample)
IL (1) IL158641A0 (enExample)
MX (1) MXPA03010943A (enExample)
NO (1) NO20035313L (enExample)
NZ (1) NZ529486A (enExample)
PL (1) PL367114A1 (enExample)
WO (1) WO2002096893A1 (enExample)
ZA (1) ZA200308570B (enExample)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7105551B2 (en) * 2000-12-20 2006-09-12 Smithkline Beecham Corporation Thiazole derivatives for treating PPAR related disorders
BR0311834A (pt) 2002-06-19 2005-04-12 Lilly Co Eli Composto, composição farmacêutica, métodos para mudular um receptor ativado por proliferador de peroxisoma, para tratar e prevenir diabetes mellitus em um mamìfero e para tratar sìndrome x em um mamìfero, e, uso de um composto ou seu sal farmaceuticamente aceitável
TW200400816A (en) 2002-06-26 2004-01-16 Lilly Co Eli Tricyclic steroid hormone nuclear receptor modulators
US7553867B2 (en) 2002-09-06 2009-06-30 Takeda Pharmaceutical Company Limited Furan or thiophene derivative and medicinal use thereof
EP1680131A4 (en) 2003-08-01 2009-05-27 Janssen Pharmaceutica Nv SUBSTITUTED INDOLE-O-GLUCOSIDES
EP1734930A2 (en) * 2004-04-09 2006-12-27 Smithkline Beecham Corporation Low dose pharmaceutical products
JP2009523132A (ja) * 2006-01-10 2009-06-18 スミスクライン ビーチャム コーポレーション ｛２−メチル−４−［４−メチル−２−（４−トリフルオロメチルフェニル）チアゾール−５−イルメチルチオ］フェノキシ｝−酢酸の多形体形態
WO2012168948A2 (en) * 2011-06-06 2012-12-13 Hetero Research Foundation Process for febuxostat

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100620337B1 (ko) * 1998-03-10 2006-09-13 오노 야꾸힝 고교 가부시키가이샤 카르복실산 유도체와 그 유도체를 유효 성분으로서함유하는 약제
PE20011010A1 (es) * 1999-12-02 2001-10-18 Glaxo Group Ltd Oxazoles y tiazoles sustituidos como agonista del receptor activado por el proliferador de peroxisomas humano
AU2002233271A1 (en) * 2000-12-20 2002-07-01 Glaxo Group Limited Substitued oxazoles and thiazoles as hppar alpha agonists
GB0111523D0 (en) * 2001-05-11 2001-07-04 Glaxo Group Ltd Chemical compounds
GB0113233D0 (en) * 2001-05-31 2001-07-25 Glaxo Group Ltd Chemical compounds

Also Published As

Publication number Publication date
KR20040007631A (ko) 2004-01-24
NO20035313D0 (no) 2003-11-28
CO5540298A2 (es) 2005-07-29
BR0209892A (pt) 2004-06-08
CA2448101A1 (en) 2002-12-05
HUP0400117A3 (en) 2005-09-28
US7244849B2 (en) 2007-07-17
CZ20033256A3 (en) 2004-04-14
EP1395572B1 (en) 2006-01-11
DE60208682T2 (de) 2006-08-24
US20040242657A1 (en) 2004-12-02
ES2256493T3 (es) 2006-07-16
AU2002317764B2 (en) 2005-01-06
JP2004532265A (ja) 2004-10-21
WO2002096893A1 (en) 2002-12-05
HUP0400117A2 (hu) 2005-03-29
PL367114A1 (en) 2005-02-21
MXPA03010943A (es) 2004-02-27
NO20035313L (no) 2003-12-09
ATE315556T1 (de) 2006-02-15
CN1551871A (zh) 2004-12-01
EP1395572A1 (en) 2004-03-10
DE60208682D1 (de) 2006-04-06
ZA200308570B (en) 2005-02-03
NZ529486A (en) 2005-12-23
IL158641A0 (en) 2004-05-12

Similar Documents

Publication Publication Date Title
MY134892A (en) Substituted 2-thio-3,5-dicyano-4-phenyl-6-aminopyridines and their use
MY120090A (en) Chemical compounds.
GB9822473D0 (en) Chemical compounds
GB0111523D0 (en) Chemical compounds
MXPA05009668A (es) Proceso libre de azida para preparar compuestos de 1,2-diamino.
GB0318343D0 (en) No title
MXPA03004426A (es) Proceso quimico y nuevos intermediarios.
CY1106743T1 (el) Μεθοδος παρασκευης θειαμεθοξαμης
PL371127A1 (en) 6-aminomorphinane derivatives, method for the production and use thereof
YU61103A (sh) Postupci za produkciju supstituisanih 2-(2-piridilmetil) sulfinil-1h-benzimidazola
JO2413B1 (en) Benzoxazine derivatives and their use
YU55003A (sh) Poboljšani postupak za sintezu karbapenema
GB0113232D0 (en) Chemical process
BR0209901A (pt) Processos para a sìntese de derivados de 2,3-dihidro-1,4-dioxino-[2,3-f] quinolina
TR200302288T2 (tr) Terapi için yeni bileşikler ve metotlar.
SG165159A1 (en) Process for preparing 6-alkylidene penem derivatives
MY130656A (en) Benzo [g] quinoline derivatives for treating glaucoma and myopia
AU2956302A (en) A process for the preparation of taxan derivatives
WO2004039776A3 (en) A process for the preparation of benzyl 2-oxo-4- (heteroaryl) dithio-alpha-isoprenyl-1- azetidineazetate derivatives
SG149005A1 (en) Process for the preparation of thiazolopyrimidines
WO2002072567A3 (en) Heterocyclic compounds, process for their preparation and pharmaceutical compositions containing them
MXPA04004937A (es) Proceso para preparar 3,3??,3,6??,-tetraalquil-2,2??-bifenoles y 3,??,6,??-tetraalquil-5,??-dihalo-2,??-bifenoles.
HU0201262D0 (enExample)
IL161974A0 (en) N-methyl-homocystines, use thereof and method for the production thereof
WO2004096828A3 (fr) Nouveau procede et intermediaires de preparation de composes 19-nor-steroïdes

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)